EFFECT OF HUMAN RECOMBINANT MULLERIAN INHIBITING SUBSTANCE ON ISOLATED EPITHELIAL AND MESENCHYMAL CELLS DURING MULLERIAN DUCT REGRESSION IN THE RAT

被引:49
|
作者
TSUJI, M
SHIMA, H
YONEMURA, CY
BRODY, J
DONAHOE, PK
CUNHA, GR
机构
[1] UNIV CALIF SAN FRANCISCO, DEPT ANAT, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF SAN FRANCISCO, CTR REPROD ENDOCRINOL, SAN FRANCISCO, CA 94143 USA
[3] MASSACHUSETTS GEN HOSP, DEPT SURG, BOSTON, MA 02114 USA
[4] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA
关键词
D O I
10.1210/en.131.3.1481
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of human recombinant Mullerian Inhibiting Substance (MIS) on the regression of the Mullerian duct (MD) of female rat fetuses was examined in vitro to determine whether MIS acts on MD epithelium and/or mesenchyme at the critical periods of sexual differentiation. Urogenital ridges (URs) of female rat fetuses at 14.5- to 18.5-days of gestation (plug day = 0) were cultured for 3 days with or without recombinant human MIS in CMRL 1066 medium with 10% female fetal calf serum. In URs from 14.5- and 15.5-day-old fetuses, the cranial portion of the MD regressed almost completely during the 3-day culture period in the presence of MIS, whereas the caudal half to third of the MD remained intact but tapered to a fine point cranially. MDs survived in URs from 16.5-day-old fetuses cultured in the presence of MIS except that the cranial portion of the MDs was deformed. MIS did not elicit regression of MDs in URs obtained from 17.5- and 18.5-day-old fetuses, but instead caused the MD epithelium to form bulges projecting into the mesenchyme. MD epithelium at 15.5-days of gestation was separated from the surrounding UR mesenchyme, and both components (MD epithelium and mesenchyme) were cultured separately for 3 days in the presence or absence of MIS. Both epithelial and mesenchymal cells survived in the presence or absence of MIS. MD epithelium formed typical epithelial colonies, whereas UR mesenchyme spread as fibroblastic cells. Analysis of labeling index after incorporation of [H-3] thymidine demonstrated that MD epithelial DNA synthesis was not influenced by MIS. In contrast, mesenchymal labeling index was reduced significantly by MIS. This effect of MIS on UR mesenchyme in conjunction with earlier histological observations of mesenchymal condensation during MD regression and an absence of direct effects of MIS on the epithelium suggests that MIS elicits its effect on the MD epithelium via the surrounding mesenchyme.
引用
收藏
页码:1481 / 1488
页数:8
相关论文
共 50 条
  • [31] CELLULAR-LOCALIZATION OF MULLERIAN INHIBITING SUBSTANCE MESSENGER-RIBONUCLEIC-ACID DURING HUMAN OVARIAN FOLLICULAR DEVELOPMENT
    WHITMAN, GF
    PANTAZIS, CG
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 165 (06) : 1881 - 1886
  • [32] Mullerian inhibiting substance is required for sexually dimorphic proliferation of germ cells during gonadal sex differentiation in medaka (Oryzias latipes)
    Shiraishi, E
    Yoshinaga, N
    Miura, T
    Wakamatsu, Y
    Ozato, K
    Abe, S
    Kitano, T
    JOURNAL OF EXPERIMENTAL ZOOLOGY PART A-ECOLOGICAL AND INTEGRATIVE PHYSIOLOGY, 2006, 305A (02): : 177 - 177
  • [33] CHANGING PATTERNS OF FIBRONECTIN, LAMININ, TYPE-IV COLLAGEN, AND A BASEMENT-MEMBRANE PROTEOGLYCAN DURING RAT MULLERIAN DUCT REGRESSION
    IKAWA, H
    TRELSTAD, RL
    HUTSON, JM
    MANGANARO, TF
    DONAHOE, PK
    DEVELOPMENTAL BIOLOGY, 1984, 102 (01) : 260 - 263
  • [34] Human ovarian cancer, cell lines, and primary ascites cells express the human mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS
    Masiakos, PT
    MacLaughlin, DT
    Maheswaran, S
    Teixeira, J
    Fuller, AF
    Shah, PC
    Kehas, DJ
    Kenneally, MK
    Dombkowski, DM
    Ha, TU
    Preffer, FI
    Donahoe, PK
    CLINICAL CANCER RESEARCH, 1999, 5 (11) : 3488 - 3499
  • [35] Effect of Metformin during In-Vitro Fertilization (IVF) on Follicular Fluid Mullerian Inhibiting Substance (MIS) Levels in Polycystic Ovarian Syndrome (PCOS)
    Moore, Andrew K.
    McCoy, Travis W.
    Archer, Johanna S.
    Bohler, Henry
    Nakajima, Steven T.
    Siow, Yong
    Fallat, Mary
    REPRODUCTIVE SCIENCES, 2011, 18 (03) : 342A - 342A
  • [36] Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo
    Pieretti-Vanmarcke, R
    Donahoe, PK
    Szotek, P
    Manganaro, T
    Lorenzen, MK
    Lorenzen, J
    Connolly, DC
    Halpern, EF
    MacLaughlin, DT
    CLINICAL CANCER RESEARCH, 2006, 12 (05) : 1593 - 1598
  • [37] THE INHIBITORY EFFECTS OF MULLERIAN-INHIBITING SUBSTANCE ON EPIDERMAL GROWTH-FACTOR INDUCED PROLIFERATION AND PROGESTERONE PRODUCTION OF HUMAN GRANULOSA-LUTEAL CELLS
    KIM, JH
    SEIBEL, MM
    MACLAUGHLIN, DT
    DONAHOE, PK
    RANSIL, BJ
    HAMETZ, PA
    RICHARDS, CJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (03): : 911 - 917
  • [38] Thyroid hormone and follicle-stimulating hormone regulate Mullerian-inhibiting substance messenger ribonucleic acid expression in cultured neonatal rat Sertoli cells
    Arambepola, NK
    Bunick, D
    Cooke, PS
    ENDOCRINOLOGY, 1998, 139 (11) : 4489 - 4495
  • [39] Endogenous expression of Mullerian inhibiting substance in early postnatal rat Sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites
    Watanabe, K
    Clarke, TR
    Lane, AH
    Wang, XZ
    Donahoe, PK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) : 1624 - 1629
  • [40] EFFECT OF SECRETIN ON INTRACELLULAR PH REGULATION IN ISOLATED RAT BILE-DUCT EPITHELIAL-CELLS
    ALVARO, D
    CHO, WK
    MENNONE, A
    BOYER, JL
    JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03): : 1314 - 1325